J.W. Cole Advisors Inc. reduced its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 31.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,177 shares of the medical research company’s stock after selling 2,839 shares during the […]

Capital Research Global Investors lessened its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 7.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,914,901 shares of the medical research company’s stock after selling 247,761 shares during the period. […]

Capital International Sarl raised its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 7.4% in the fourth quarter, Holdings Channel reports. The fund owned 106,535 shares of the medical research company’s stock after buying an additional 7,317 shares during the period. Thermo Fisher Scientific makes up approximately 1.0% of Capital International Sarl’s […]

Vise Technologies Inc. lifted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 44.0% during the fourth quarter, Holdings Channel reports. The institutional investor owned 7,707 shares of the medical research company’s stock after acquiring an additional 2,354 shares during the quarter. Vise Technologies Inc.’s holdings in Thermo Fisher Scientific were worth […]

Anchor Capital Advisors LLC cut its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 4.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 26,427 shares of the medical research company’s stock after selling 1,154 shares during the quarter. […]

Natixis Advisors LLC boosted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 22.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 588,805 shares of the medical research company’s stock after purchasing an additional 106,375 shares during the […]